{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:26:59Z","timestamp":1789406819775,"version":"build-2803163510"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L248066"],"award-info":[{"award-number":["L248066"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82502776"],"award-info":[{"award-number":["82502776"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2024-I2M-TS-020"],"award-info":[{"award-number":["2024-I2M-TS-020"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZB20240073"],"award-info":[{"award-number":["GZB20240073"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M781355"],"award-info":[{"award-number":["2025M781355"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2023-PT310-04"],"award-info":[{"award-number":["2023-PT310-04"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biotechadv.2026.108902","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:09:49Z","timestamp":1776701389000},"page":"108902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Unveiling the mechanistic principles and engineered exploitation of bacteria and derivatives in precision drug delivery"],"prefix":"10.1016","volume":"90","author":[{"given":"Wen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beihan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biotechadv.2026.108902_bb0005","doi-asserted-by":"crossref","first-page":"16031","DOI":"10.1038\/mtm.2016.31","article-title":"A scalable method for the production of high-titer and high-quality adeno-associated type 9 vectors using the HSV platform","volume":"3","author":"Adamson-Small","year":"2016","journal-title":"Mol. Ther. Methods Clin."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.108902_bb0010","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1099\/ijsem.0.001485","volume":"66","author":"Adeolu","year":"2016","journal-title":"Int. J. Syst. Evol. Microbiol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0015","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.biotechadv.2018.01.016","article-title":"Bacterial type III secretion system as a protein delivery tool for a broad range of biomedical applications","volume":"36","author":"Bai","year":"2018","journal-title":"Biotechnol. Adv."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108902_bb0020","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01478-23","article-title":"The tip protein PAAR is required for the function of the type VI secretion system","volume":"11","author":"Beauvois","year":"2023","journal-title":"Microbiol. Spectrum"},{"key":"10.1016\/j.biotechadv.2026.108902_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2022.102403","article-title":"Cryo-EM of the injectisome and type III secretion systems","volume":"75","author":"Bergeron","year":"2022","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115663","article-title":"Bioinspired approaches to encapsulate and deliver bacterial live biotherapeutic products","volume":"225","author":"Brittain","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s44259-025-00100-8","article-title":"Antimicrobial resistance and vaccines in Enterobacteriaceae including extraintestinal pathogenic Escherichia coli and Klebsiella pneumoniae","volume":"3","author":"Cabrera","year":"2025","journal-title":"NPJ. Antimicrob. Resist."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0040","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jconrel.2020.07.009","article-title":"Bacteria and bacterial derivatives as drug carriers for cancer therapy","volume":"326","author":"Cao","year":"2020","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0045","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s42003-020-1072-4","article-title":"Salmonella-based platform for efficient delivery of functional binding proteins to the cytosol","volume":"3","author":"Chabloz","year":"2020","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0050","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI79213","article-title":"Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy","volume":"125","author":"Chandler","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108902_bb0055","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.cell.2025.02.002","article-title":"Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization","volume":"188","author":"Chang","year":"2025","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/acs.nanolett.9b02182","article-title":"Bioengineering bacterial vesicle-coated polymeric nanomedicine for enhanced cancer immunotherapy and metastasis prevention","volume":"20","author":"Chen","year":"2020","journal-title":"Nano Lett."},{"issue":"42","key":"10.1016\/j.biotechadv.2026.108902_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202507820","article-title":"Engineering bacteria as living therapeutics in cancer therapy","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108902_bb0070","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1086\/315497","article-title":"Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium","volume":"181","author":"Clairmont","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0075","article-title":"Size exclusion chromatography to analyze bacterial outer membrane vesicle heterogeneity","volume":"169","author":"Collins","year":"2021","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0080","doi-asserted-by":"crossref","DOI":"10.1128\/ecosalplus.8.3.1.2","article-title":"The life of commensal Escherichia coli in the mammalian intestine","volume":"1","author":"Conway","year":"2004","journal-title":"EcoSal Plus"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108902_bb0085","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41579-023-00974-3","article-title":"Structural and functional diversity of type IV secretion systems","volume":"22","author":"Costa","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/antibiotics14010104","article-title":"A versatile approach to reprogram the specificity of the R2-Type tailocin towards different serotypes of Escherichia coli and Klebsiella pneumoniae","volume":"14","author":"Dams","year":"2025","journal-title":"Antibiotics (Basel)."},{"issue":"13","key":"10.1016\/j.biotechadv.2026.108902_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12161","article-title":"Microbiota-derived extracellular vesicles in interkingdom communication in the gut","volume":"10","author":"D\u00edaz-Garrido","year":"2021","journal-title":"J. Extracell. Vesicles"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108902_bb0100","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2337\/db14-0635","article-title":"Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes","volume":"63","author":"Duan","year":"2015","journal-title":"Diabetes"},{"issue":"40","key":"10.1016\/j.biotechadv.2026.108902_bb0105","article-title":"Genetically programmable self-regenerating bacterial hydrogels","volume":"31","author":"Duraj-Thatte","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0110","series-title":"Live biotherapeutic products (LBPs): European pharmacopoeia commission sets unprecedented quality requirements","author":"EDQM","year":"2018"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0115","doi-asserted-by":"crossref","first-page":"2397874","DOI":"10.1080\/19490976.2024.2397874","article-title":"Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Escherichia coli Nissle 1917 strain","volume":"16","author":"Falzone","year":"2024","journal-title":"Gut Microbes"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108902_bb0120","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1515\/hsz-2022-0350","article-title":"Mycobacterial type VII secretion systems","volume":"404","author":"Famelis","year":"2023","journal-title":"Biol. Chem."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0125","series-title":"Early clinical trials with live biotherapeutic products: chemistry, manufacturing, and control information","author":"FDA","year":"2016"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12951-025-03191-7","article-title":"RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2","volume":"23","author":"Feng","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108902_bb0135","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1158\/2159-8290.CD-11-0201","article-title":"A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy","volume":"2","author":"Flentie","year":"2012","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108902_bb0140","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2934","article-title":"Engineering the perfect (bacterial) cancer therapy","volume":"10","author":"Forbes","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"5418","key":"10.1016\/j.biotechadv.2026.108902_bb0145","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.284.5418.1322","article-title":"Type III secretion machines: bacterial devices for protein delivery into host cells","volume":"284","author":"Gal\u00e1n","year":"1999","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108902_bb0150","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.7150\/thno.51988","article-title":"RGD-expressed bacterial membrane-derived nanovesicles enhance cancer therapy via multiple tumorous targeting","volume":"11","author":"Gao","year":"2021","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0155","doi-asserted-by":"crossref","first-page":"2291164","DOI":"10.1080\/19490976.2023.2291164","article-title":"Bifidobacterium mechanisms of immune modulation and tolerance","volume":"15","author":"Gavzy","year":"2023","journal-title":"Gut Microbes"},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108902_bb0160","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1515\/hsz-2013-0162","article-title":"Structural comparison of the transport units of type V secretion systems","volume":"394","author":"Gawarzewski","year":"2013","journal-title":"Biol. Chem."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0165","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02368-14","article-title":"A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity","volume":"6","author":"Gebhart","year":"2015","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0170","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1038\/s41467-021-23777-7","article-title":"The extracellular contractile injection system is enriched in environmental microbes and associates with numerous toxins","volume":"12","author":"Geller","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0175","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/s41467-025-57153-6","article-title":"Oral delivery of therapeutic proteins by engineered bacterial type zero secretion system","volume":"16","author":"Gong","year":"2025","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108902_bb0180","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/j.celrep.2017.02.057","article-title":"Recombinant BCG expressing ESX-1 of Mycobacterium marinum combines low virulence with cytosolic immune signaling and improved TB protection","volume":"18","author":"Groschel","year":"2017","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108902_bb0185","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/tra.12488","article-title":"The outer membrane vesicles: secretion system type zero","volume":"18","author":"Guerrero-Mandujano","year":"2017","journal-title":"Traffic"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0190","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1021\/nn405724x","article-title":"Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy","volume":"8","author":"Gujrati","year":"2014","journal-title":"ACS Nano"},{"issue":"6622","key":"10.1016\/j.biotechadv.2026.108902_bb0195","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.add9667","article-title":"Engineering bacteria as interactive cancer therapies","volume":"378","author":"Gurbatri","year":"2022","journal-title":"Science"},{"issue":"43","key":"10.1016\/j.biotechadv.2026.108902_bib797","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2408509121","article-title":"Delivery of functional Cas:DNA nucleoprotein complexes into recipient bacteria through a type IV secretion system","volume":"121","author":"Guzm\u00e1n-Herrador","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0200","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s44222-023-00119-4","article-title":"Bacterial therapies at the interface of synthetic biology and nanomedicine","volume":"2","author":"Hahn","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12967-021-02910-6","article-title":"Translational precision medicine: an industry perspective","volume":"19","author":"Hartl","year":"2021","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00240-004-0445-3","article-title":"Intestinal transport of an obdurate anion: oxalate","volume":"33","author":"Hatch","year":"2005","journal-title":"Urol. Res."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108902_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112781","article-title":"Structure and assembly of type VI secretion system cargo delivery vehicle","volume":"42","author":"He","year":"2023","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108902_bb0220","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tibtech.2021.08.002","article-title":"Discovery and delivery strategies for engineered live biotherapeutic products","volume":"40","author":"Heavey","year":"2022","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0225","doi-asserted-by":"crossref","first-page":"1264877","DOI":"10.3389\/fmicb.2023.1264877","article-title":"Evolutionary and ecological role of extracellular contractile injection systems: from threat to weapon","volume":"14","author":"Heiman","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0230","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3389\/fmicb.2017.01588","article-title":"In vitro evaluation of the impact of the probiotic E. coli Nissle 1917 on Campylobacter jejuni's invasion and intracellular survival in human colonic cells","volume":"8","author":"Helmy","year":"2017","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108902_bb0235","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01115-21","article-title":"Engineered type six secretion systems deliver active exogenous effectors and cre recombinase","volume":"12","author":"Hersch","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.biotechadv.2026.108902_bb0240","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.82437","article-title":"Antibacterial T6SS effectors with a VRR-Nuc domain are structure-specific nucleases","volume":"11","author":"Hespanhol","year":"2022","journal-title":"Elife"},{"issue":"18","key":"10.1016\/j.biotechadv.2026.108902_bb0245","doi-asserted-by":"crossref","first-page":"9065","DOI":"10.3390\/ijms26189065","article-title":"Probiotics in IBD: evidence and perspectives on patient health and disease management","volume":"26","author":"Hijov\u00e1","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0250","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41551-017-0181-y","article-title":"Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention","volume":"2","author":"Ho","year":"2018","journal-title":"Nat. Biomed. Eng."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.108902_bb0255","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0260","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/gut.49.1.47","article-title":"Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection","volume":"49","author":"Hudault","year":"2001","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108902_bb0265","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nbt.4222","article-title":"Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria","volume":"36","author":"Isabella","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"8082","key":"10.1016\/j.biotechadv.2026.108902_bb0270","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41586-025-09415-y","article-title":"Commensal yeast promotes Salmonella Typhimurium virulence","volume":"645","author":"Jaswal","year":"2025","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108902_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034214","article-title":"CD8 T-cell induction against vascular endothelial growth factor receptor 2 by Salmonella for vaccination purposes against a murine melanoma","volume":"7","author":"Jellbauer","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0280","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cell.2019.02.020","article-title":"Cryo-EM structure and assembly of an extracellular contractile injection system","volume":"177","author":"Jiang","year":"2019","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.biotechadv.2026.108902_bb0285","doi-asserted-by":"crossref","first-page":"eabm2343","DOI":"10.1126\/sciadv.abm2343","article-title":"N-terminal signal peptides facilitate the engineering of PVC complex as a potent protein delivery system","volume":"8","author":"Jiang","year":"2022","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0290","doi-asserted-by":"crossref","first-page":"2473522","DOI":"10.1080\/19490976.2025.2473522","article-title":"Interbacterial warfare in the human gut: insights from Bacteroidales\u2019 perspective","volume":"17","author":"Jiang","year":"2025","journal-title":"Gut Microbes"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108902_bb0295","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41589-023-01331-4","article-title":"Cascading conjugates","volume":"19","author":"Johnson","year":"2023","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108902_bb0300","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/MMBR.00011-07","article-title":"The autodisplay story, from discovery to biotechnical and biomedical applications","volume":"71","author":"Jose","year":"2007","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.108902_bb0305","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/j.1462-5822.2008.01187.x","article-title":"Type IV secretion systems: tools of bacterial horizontal gene transfer and virulence","volume":"10","author":"Juhas","year":"2008","journal-title":"Cell. Microbiol."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108902_bb0310","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fny094","article-title":"Type I secretion system-it takes three and a substrate","volume":"365","author":"Kanonenberg","year":"2018","journal-title":"FEMS Microbiol. Lett."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108902_bb0315","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1074\/jbc.M307628200","article-title":"Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles","volume":"279","author":"Kesty","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0320","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.biomaterials.2016.10.037","article-title":"Bacterial protoplast-derived nanovesicles for tumor targeted delivery of chemotherapeutics","volume":"113","author":"Kim","year":"2017","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.biotechadv.2026.108902_bib796","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S1473-3099(24)00424-9","article-title":"Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial","volume":"24","author":"Kim","year":"2024","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0325","article-title":"Robust performance of a live bacterial therapeutic chassis lacking the colibactin gene cluster","volume":"18","author":"Koestler","year":"2023","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0330","doi-asserted-by":"crossref","DOI":"10.1128\/ecosalplus.esp-0034-2018","article-title":"Architecture, function, and substrates of the Type II secretion system","volume":"8","author":"Korotkov","year":"2019","journal-title":"EcoSal Plus"},{"key":"10.1016\/j.biotechadv.2026.108902_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2025.128291","article-title":"Importance of chick origin in introducing multidrug-resistant and extended-spectrum beta-lactamase-producing Enterobacteriaceae into an organic broiler farm","volume":"301","author":"Korves","year":"2025","journal-title":"Microbiol. Res."},{"issue":"7956","key":"10.1016\/j.biotechadv.2026.108902_bb0340","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-023-05870-7","article-title":"Programmable protein delivery with a bacterial contractile injection system","volume":"616","author":"Kreitz","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.biotechadv.2026.108902_bb0345","article-title":"Targeted delivery of diverse biomolecules with engineered bacterial nanosyringes","author":"Kreitz","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0350","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.micro.091208.073413","article-title":"Biological functions and biogenesis of secreted bacterial outer membrane vesicles","volume":"64","author":"Kulp","year":"2010","journal-title":"Ann. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0355","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00253-011-3695-3","article-title":"Engineering bacteria toward tumor targeting for cancer treatment: current state and perspectives","volume":"93","author":"Lee","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0360","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/toxins12020103","article-title":"Bacteriocins of Listeria monocytogenes and their potential as a virulence factor","volume":"12","author":"Lee","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.biotechadv.2026.108902_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115579","article-title":"Designing live bacterial therapeutics for cancer","volume":"221","author":"Lee","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108902_bb0370","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0375","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s41467-020-14963-0","article-title":"Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0380","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jconrel.2020.04.031","article-title":"Bacterial outer membrane vesicles as a platform for biomedical applications: An update","volume":"323","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108902_bb0385","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02143-23","article-title":"Ligand-displaying Escherichia coli cells and minicells for programmable delivery of toxic payloads via type IV secretion systems","volume":"14","author":"Li","year":"2023","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0390","doi-asserted-by":"crossref","first-page":"2530156","DOI":"10.1080\/19490976.2025.2530156","article-title":"Minimal logic gates for probiotic Escherichia coli Nissle 1917 sensing and treatment of dual-bacteria intestinal infection","volume":"17","author":"Li","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biotechadv.2026.108902_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2025.103375","article-title":"Programmable probiotics as next-generation living therapeutics: bridging synthetic biology and precision medicine","volume":"96","author":"Li","year":"2025","journal-title":"Curr. Opin. Biotechnol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0400","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s42003-025-07748-y","article-title":"Genomic diversity of mcr-carrying plasmids and the role of type IV secretion systems in IncI2 plasmids conjugation","volume":"8","author":"Li","year":"2025","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0405","doi-asserted-by":"crossref","first-page":"2645873","DOI":"10.1080\/21505594.2026.2645873","article-title":"Functional regulation and cross-talk of type III and Type VI secretion systems in Salmonella","volume":"17","author":"Li","year":"2026","journal-title":"Virulence"},{"key":"10.1016\/j.biotechadv.2026.108902_bb0410","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01575-6","article-title":"Engineered outer membrane vesicles enhance solid tumour CAR-T cell therapy","author":"Li","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2024.102465","article-title":"The expanding universe of contractile injection systems in bacteria","volume":"79","author":"Lin","year":"2024","journal-title":"Curr. Opin. Microbiol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0420","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/s41467-020-16169-w","article-title":"LITESEC-T3SS-Light-controlled protein delivery into eukaryotic cells with high spatial and temporal resolution","volume":"11","author":"Lindner","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1902718","article-title":"Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway","volume":"13","author":"Liu","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biotechadv.2026.108902_bb0430","first-page":"169","article-title":"Bacterial extracellular vesicles as bioactive nanocarriers for drug delivery: advances and perspectives","volume":"14","author":"Liu","year":"2022","journal-title":"Bioact. Mater."},{"issue":"2023","key":"10.1016\/j.biotechadv.2026.108902_bb0435","article-title":"Bone-targeted bioengineered bacterial extracellular vesicles delivering siRNA to ameliorate osteoporosis","volume":"255","author":"Liu","year":"2023","journal-title":"Compos. Part B Eng."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108902_bb0440","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12429","article-title":"Synthetic biology-based bacterial extracellular vesicles displaying BMP-2 and CXCR4 to ameliorate osteoporosis","volume":"13","author":"Liu","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108902_bb0445","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tim.2023.10.006","article-title":"Plasmid-mediated colistin-resistance genes: mcr","volume":"32","author":"Liu","year":"2024","journal-title":"Trends Microbiol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0450","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00253-024-13378-x","article-title":"Precision tumor treatment utilizing bacteria: principles and future perspectives","volume":"109","author":"Liu","year":"2025","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"7402","key":"10.1016\/j.biotechadv.2026.108902_bb0455","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nature11079","article-title":"Atomic model of the type III secretion system needle","volume":"486","author":"Loquet","year":"2012","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108902_bb0460","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.chom.2023.05.005","article-title":"Bacterial molecular syringe for drug delivery","volume":"31","author":"Lu","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.biotechadv.2026.108902_bb0465","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.tips.2022.02.002","article-title":"Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics","volume":"43","author":"Lynch","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.108902_bb0470","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1039\/C9MD00146H","article-title":"On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome","volume":"10","author":"Lyons","year":"2019","journal-title":"Medchemcomm"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108902_bb0475","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.str.2020.12.009","article-title":"Cryo-EM structure of the EspA filament from enteropathogenic Escherichia coli: revealing the mechanism of effector translocation in the T3SS","volume":"29","author":"Lyons","year":"2021","journal-title":"Structure"},{"issue":"15","key":"10.1016\/j.biotechadv.2026.108902_bb0480","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1038\/s44318-024-00135-z","article-title":"Cryo-EM structure of a conjugative type IV secretion system suggests a molecular switch regulating pilus biogenesis","volume":"43","author":"Mace","year":"2024","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0485","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2958.2006.05522.x","article-title":"Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response","volume":"63","author":"McBroom","year":"2007","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0490","doi-asserted-by":"crossref","first-page":"1441290","DOI":"10.3389\/frmbi.2024.1441290","article-title":"Navigating regulatory and analytical challenges in live biotherapeutic product development and manufacturing","volume":"3","author":"Microbiome Therapeutics Innovation, G","year":"2024","journal-title":"Front. Microbiomes."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0495","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1038\/s41467-026-68710-y","article-title":"A comprehensive catalogue of receptor-binding domains in extracellular contractile injection systems","volume":"17","author":"Nachmias","year":"2026","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.108902_bb0500","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202500084","article-title":"Optimization of the isolation method for large-scale production of synthetic bacterial vesicles for cancer immunotherapy","volume":"8","author":"Ordouzadeh","year":"2025","journal-title":"Adv. Therap."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108902_bb0505","doi-asserted-by":"crossref","first-page":"17057","DOI":"10.1038\/nmicrobiol.2017.57","article-title":"Next-generation probiotics: the spectrum from probiotics to live biotherapeutics","volume":"2","author":"O'Toole","year":"2017","journal-title":"Nat. Microbiol."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.108902_bb0510","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/1061186X.2017.1401076","article-title":"Novel advances in targeted drug delivery","volume":"26","author":"Ozturk-Atar","year":"2018","journal-title":"J. Drug Target."},{"issue":"10061","key":"10.1016\/j.biotechadv.2026.108902_bb0515","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","article-title":"Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study","volume":"388","author":"Parikh","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108902_bb0520","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.7150\/thno.16135","article-title":"RGD Peptide cell-surface display enhances the targeting and therapeutic efficacy of attenuated Salmonella-mediated cancer therapy","volume":"6","author":"Park","year":"2016","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108902_bb0525","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1099\/mic.0.000468","article-title":"Commensal-derived OMVs elicit a mild proinflammatory response in intestinal epithelial cells","volume":"163","author":"Patten","year":"2017","journal-title":"Microbiology (Reading)"},{"key":"10.1016\/j.biotechadv.2026.108902_bb0530","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jare.2019.04.003","article-title":"Phage tail-like particles are versatile bacterial nanomachines - A mini-review","volume":"19","author":"Patz","year":"2019","journal-title":"J. Adv. Res."},{"issue":"27","key":"10.1016\/j.biotechadv.2026.108902_bb0535","doi-asserted-by":"crossref","first-page":"eaba2735","DOI":"10.1126\/sciadv.aba2735","article-title":"Engineering bacterial outer membrane vesicles as transdermal nanoplatforms for photo-TRAIL-programmed therapy against melanoma","volume":"6","author":"Peng","year":"2020","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108902_bb0540","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41565-020-0759-5","article-title":"A framework for designing delivery systems","volume":"15","author":"Poon","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"16","key":"10.1016\/j.biotechadv.2026.108902_bb0545","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1007\/s00253-023-12653-7","article-title":"A step forward to the optimized HlyA type 1 secretion system through directed evolution","volume":"107","author":"Pourhassan","year":"2023","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0550","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1038\/s41467-019-13336-6","article-title":"Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut","volume":"10","author":"Praveschotinunt","year":"2019","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108902_bb0555","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/s41564-018-0238-z","article-title":"Mechanism of loading and translocation of type VI secretion system effector Tse6","volume":"3","author":"Quentin","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0560","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-publhealth-040617-014158","article-title":"Precision medicine from a public health perspective","volume":"39","author":"Ramaswami","year":"2018","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.biotechadv.2026.108902_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21775\/cimb.025.001","article-title":"Secretion systems used by bacteria to subvert host functions","volume":"25","author":"Rapisarda","year":"2018","journal-title":"Curr. Issues Mol. Biol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0570","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.celrep.2019.06.019","article-title":"A bacterial phage tail-like structure kills eukaryotic cells by injecting a nuclease effector","volume":"28","author":"Rocchi","year":"2019","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0575","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41467-022-28163-5","article-title":"Genetically stable CRISPR-based kill switches for engineered microbes","volume":"13","author":"Rottinghaus","year":"2022","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108902_bb0580","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00436-22","article-title":"DNA transport through the dynamic type IV secretion system","volume":"91","author":"Ryan","year":"2023","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108902_bb0585","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.surg.2017.09.036","article-title":"Low dose chemotherapy combined with attenuated Salmonella decreases tumor burden and is less toxic than high dose chemotherapy in an autochthonous murine model of breast cancer","volume":"163","author":"Saltzman","year":"2018","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.108902_bb0590","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41591-019-0485-4","article-title":"Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism","volume":"25","author":"Scheiman","year":"2019","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108902_bb0595","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrmicro3525","article-title":"Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions","volume":"13","author":"Schwechheimer","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114364","article-title":"Engineered microbial systems for advanced drug delivery","volume":"187","author":"Shen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108902_bb0605","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.cell.2025.01.017","article-title":"Engineered commensals for targeted nose-to-brain drug delivery","volume":"188","author":"Shen","year":"2025","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108902_bb0610","doi-asserted-by":"crossref","DOI":"10.1111\/1751-7915.70057","article-title":"Living engineered bacterial therapeutics: emerging affordable precision interventions","volume":"17","author":"Srivastava","year":"2024","journal-title":"Microb. Biotechnol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0615","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1164\/rccm.201802-0366OC","article-title":"Dose optimization of H56:IC31 vaccine for Tuberculosis-endemic populations. A double-blind, placebo-controlled, dose-selection trial","volume":"199","author":"Suliman","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0620","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymben.2024.10.002","article-title":"Improving the growth and intestinal colonization of Escherichia coli Nissle 1917 by strengthening its oligopeptides importation ability","volume":"86","author":"Sun","year":"2024","journal-title":"Metab. Eng."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0625","article-title":"Synlogic shuts down after PKU drug fails phase 3 trial","author":"Taylor","year":"2024","journal-title":"Pharmaphorum"},{"key":"10.1016\/j.biotechadv.2026.108902_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115331","article-title":"Targeted drug delivery systems for elemene in cancer therapy: the story thus far","volume":"166","author":"Tian","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0635","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","article-title":"Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma","volume":"120","author":"Toso","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115577","article-title":"Paving the way for bacteria-based drug delivery: biohybrid microrobots emerging from microrobotics and synthetic biology","volume":"221","author":"Totter","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0645","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41579-018-0112-2","article-title":"Types and origins of bacterial membrane vesicles","volume":"17","author":"Toyofuku","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0650","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3389\/fimmu.2018.01466","article-title":"Helicobacter pylori outer membrane vesicle size determines their mechanisms of host cell entry and protein content","volume":"9","author":"Turner","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108902_bb0655","doi-asserted-by":"crossref","DOI":"10.1002\/pro.70165","article-title":"Enhanced secretion through type 1 secretion system by grafting a calcium-binding sequence to modify the folding of cargo proteins","volume":"34","author":"Uehara","year":"2025","journal-title":"Protein Sci."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0660","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3389\/fmicb.2020.00890","article-title":"Combining protein ligation systems to expand the functionality of semi-synthetic outer membrane vesicle nanoparticles","volume":"11","author":"Van Den Berg Van Saparoea","year":"2020","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108902_bb0665","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/s42255-023-00897-6","article-title":"Efficacy and safety of a synthetic biotic for treatment of phenylketonuria: a phase 2 clinical trial","volume":"5","author":"Vockley","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0670","article-title":"Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer","volume":"49","author":"Vyas","year":"2023","journal-title":"Nanomedicine"},{"issue":"11","key":"10.1016\/j.biotechadv.2026.108902_bb0675","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/s41564-017-0020-7","article-title":"Cryo-EM structure of the extended type VI secretion system sheath\u2013tube complex","volume":"2","author":"Wang","year":"2017","journal-title":"Nat. Microbiol."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108902_bb0680","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0685","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.freeradbiomed.2024.12.013","article-title":"A bioadhesive antioxidase-overexpressed probiotic prevents radiation enteritis by scavenging the excess reactive oxygen species","volume":"227","author":"Wang","year":"2025","journal-title":"Free Radic. Biol. Med."},{"issue":"24","key":"10.1016\/j.biotechadv.2026.108902_bb0690","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1097\/CM9.0000000000003807","article-title":"Engineered bacteria for cancer therapy: advancements, challenges, and future directions","volume":"138","author":"Wang","year":"2025","journal-title":"Chin. Med. J."},{"issue":"15","key":"10.1016\/j.biotechadv.2026.108902_bb0695","first-page":"1","article-title":"VXM01 phase I study in patients with progressive glioblastoma: final results","volume":"36","author":"Wick","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0700","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13036-025-00479-y","article-title":"Engineering probiotic Escherichia coli for inflammation-responsive indoleacetic acid production using RiboJ-enhanced genetic circuits","volume":"19","author":"Woo","year":"2025","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.biotechadv.2026.108902_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114443","article-title":"Decorated bacteria and the application in drug delivery","volume":"188","author":"Wu","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.108902_bb0710","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1016\/j.apsb.2022.05.006","article-title":"Macrophage-mediated tumor-targeted delivery of engineered Salmonella typhimurium VNP20009 in anti-PD1 therapy against melanoma","volume":"12","author":"Wu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0715","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/acssynbio.2c00441","article-title":"A dueling-competent signal-sensing module guides precise delivery of cargo proteins into target cells by engineered Pseudomonas aeruginosa","volume":"12","author":"Wu","year":"2023","journal-title":"ACS Synth. Biol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0720","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41392-023-01703-1","article-title":"Camouflaging attenuated Salmonella by cryo-shocked macrophages for tumor-targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.108902_bb0725","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.tim.2023.05.010","article-title":"Bacterial extracellular vesicles: an emerging avenue to tackle diseases","volume":"31","author":"Xie","year":"2023","journal-title":"Trends Microbiol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108902_bb0730","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41564-022-01059-2","article-title":"Identification and structure of an extracellular contractile injection system from the marine bacterium Algoriphagus machipongonensis","volume":"7","author":"Xu","year":"2022","journal-title":"Nat. Microbiol."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.108902_bb0735","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10719-023-10124-9","article-title":"Mucin glycans and their degradation by gut microbiota","volume":"40","author":"Yamaguchi","year":"2023","journal-title":"Glycoconj. J."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.108902_bb0740","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3390\/biom11050738","article-title":"Metabolomics-guided hypothesis generation for mechanisms of intestinal protection by live biotherapeutic products","volume":"11","author":"Ye","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.biotechadv.2026.108902_bb0745","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/srep00436","article-title":"Explicit hypoxia targeting with tumor suppression by creating an \"obligate\" anaerobic Salmonella Typhimurium strain","volume":"2","author":"Yu","year":"2012","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108902_bb0750","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s11427-022-2172-x","article-title":"SecReT6 update: a comprehensive resource of bacterial Type VI Secretion Systems","volume":"66","author":"Zhang","year":"2022","journal-title":"Sci. China Life Sci."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.108902_bb0755","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.0408422102","article-title":"Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium","volume":"102","author":"Zhao","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"376","key":"10.1016\/j.biotechadv.2026.108902_bb0760","doi-asserted-by":"crossref","first-page":"eaak9537","DOI":"10.1126\/scitranslmed.aak9537","article-title":"Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin","volume":"89","author":"Zheng","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.108902_bb0765","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1038\/s41467-022-31171-0","article-title":"Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108902_bb0770","article-title":"Targeted deprivation of methionine with engineered Salmonella leads to oncolysis and suppression of metastasis in broad types of animal tumor models","volume":"4","author":"Zhou","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.108902_bb0775","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008238","article-title":"Salmonella-mediated methionine deprivation drives immune activation and enhances immune checkpoint blockade therapy in melanoma","volume":"12","author":"Zhou","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"42","key":"10.1016\/j.biotechadv.2026.108902_bb0780","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103526118","article-title":"T6SS translocates a micropeptide to suppress STING-mediated innate immunity by sequestering manganese","volume":"118","author":"Zhu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.108902_bb0785","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2018.08.041","article-title":"Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features","volume":"174","author":"Zmora","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.biotechadv.2026.108902_bb0790","article-title":"Biotechnological applications of type 1 secretion systems","volume":"53","author":"Zohreh","year":"2021","journal-title":"Biotechnol. Adv."},{"issue":"31","key":"10.1016\/j.biotechadv.2026.108902_bb0795","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202406486","article-title":"Self-adjusting engineered probiotic for targeted tumor colonization and local therapeutics delivery","volume":"12","author":"Zou","year":"2025","journal-title":"Adv. Sci."}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975026001084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975026001084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T08:12:56Z","timestamp":1784535176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0734975026001084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":161,"alternative-id":["S0734975026001084"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2026.108902","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the mechanistic principles and engineered exploitation of bacteria and derivatives in precision drug delivery","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotechadv.2026.108902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108902"}}